ESC Premium Access

Comparative efficacy and safety of mycophenolate mofetil and azathioprine in combination with corticosteroids in the treatment of lymphocytic myocarditis

Congress Session

About the speaker

Professor Olga Blagova

I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow (Russian Federation)
2 presentations
0 follower

93 more presentations in this session

Combination of arrhythmogenic right ventricular dysplasia with left ventricular non-compaction as a special form of cardiomyopathy: clinic, diagnostics, genetic, natural course

Speaker: Professor O. Blagova (Moscow, RU)

Thumbnail

Efficacy and safety of alcohol septal ablation in adolescents and young adults with symptomatic hypertrophic obstructive cardiomyopathy

Speaker: Doctor D. Lawin (Bielefeld, DE)

Thumbnail

Cardiac rupture - the most serious complication of takotsubo syndrome

Speaker: Doctor M. Zalewska-Adamiec (Bialystok, PL)

Thumbnail

Noncompact myocardium with dilated phenotype: differences in comparison with other forms of dilated cardiomyopathy..

Speaker: Professor O. Blagova (Moscow, RU)

Thumbnail

Acute coronary syndrome with non-obstructive coronary arteries (ACS-NOCA in patients with hypertrophic cardiomyopathy

Speaker: Doctor A. Trongtorsak (Evanston, US)

Thumbnail

Access the full session

Myocardial and pericardial disease e-posters

Speakers: Professor O. Blagova, Professor O. Blagova, Doctor D. Lawin, Doctor M. Zalewska-Adamiec, Professor O. Blagova...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ACVC Premium Access

PAC use in daily clinical practice: a practical guide for fellows

19 March 2022

ESC Premium Access

Influence of cardiovascular drugs on the efficacy and safety of dapagliflozin in patients with type 2 diabetes mellitus in the DECLARE-TIMI 58 trial

27 August 2021

ESC Premium Access

Heart failure as a complication of covid-19 infection: systematic review and meta-analysis

27 August 2021

This platform is supported by

logo Novo Nordisk